Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High-Dose Vancomycin vs Daptomycin for MRSA Bacteremia
NCT01287832Phase 4Terminated
- Sponsor
- Ascension St. John
- Start
- Jun 2011
- Primary completion
- Jan 2012
- Modality
- Cyclic Peptides, Antimicrobial Peptides, Small Molecules
01
Overview
A Phase 4 trial of daptomycin in Staphylococcus aureus bacteremia (SAB), sponsored by Ascension St. John. Started Jun 2011; status: terminated.
02
Drugs
daptomycin
03
Conditions
Staphylococcus aureus bacteremia (SAB)
Beyond the preview
Go deeper on NCT01287832.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01287832.